Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / ADS
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
2.55M
-
Shares change
-
+2M
-
Total reported value, excl. options
-
$55.9M
-
Value change
-
+$44.9M
-
Number of buys
-
6
-
Number of sells
-
-1
-
Price
-
$23.01
Significant Holders of Silence Therapeutics plc - ADS (SLN) as of Q1 2021
7 filings reported holding SLN - Silence Therapeutics plc - ADS as of Q1 2021.
Silence Therapeutics plc - ADS (SLN) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.55M shares
.
Largest 7 shareholders include Lombard Odier Asset Management (USA) Corp (1.2M shares), BVF INC/IL (667K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (444K shares), Consonance Capital Management LP (222K shares), MORGAN STANLEY (10.1K shares), SG Americas Securities, LLC (5.45K shares), and UBS Group AG (0 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.